Cargando…
Optimization of formulation for enhanced intranasal delivery of insulin with translationally controlled tumor protein-derived protein transduction domain
Intranasal delivery of insulin is an alternative approach to treat diabetes, as it enables higher patient compliance than conventional therapy with subcutaneously injected insulin. However, the use of intranasal delivery of insulin is limited for insulin’s hydrophilicity and vulnerability to enzymat...
Autores principales: | Bae, Hae-Duck, Lee, Ji-Sun, Pyun, Haejun, Kim, Moonhee, Lee, Kyunglim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586149/ https://www.ncbi.nlm.nih.gov/pubmed/31210056 http://dx.doi.org/10.1080/10717544.2019.1628119 |
Ejemplares similares
-
Modified translationally controlled tumor protein-derived protein transduction domain enhances nasal delivery of exendin-4 as shown with insulin
por: Bae, Hae-Duck, et al.
Publicado: (2018) -
Modification of translationally controlled tumor protein-derived protein transduction domain for improved intranasal delivery of insulin
por: Bae, Hae-Duck, et al.
Publicado: (2018) -
Protein transduction domain of translationally controlled tumor protein: characterization and application in drug delivery
por: Maeng, Jeehye, et al.
Publicado: (2022) -
PEGylation improves the therapeutic potential of dimerized translationally controlled tumor protein blocking peptide in ovalbumin-induced mouse model of airway inflammation
por: Seo, Hyeran, et al.
Publicado: (2022) -
Allergic Inflammation Caused by Dimerized Translationally Controlled Tumor Protein is Attenuated by Cardamonin
por: Pyun, Haejun, et al.
Publicado: (2021)